Aktuelles

Bilder

10 examples
Gene Drive - intervention in the "germline" of natural diversity
previous pauseresume next

Import approval for genetically engineered maize: Did Monsanto benefit from unlawful exploitation of transitional provisions?

Authorities ‘unable to find’ original dossier as filed by Monsanto

20 April 2020 / Testbiotech is concerned that Monsanto (Bayer) unlawfully obtained an import authorisation for genetically engineered maize without a proper risk assessment as required by EU regulations. The reason: officially, Monsanto filed its application for market approval just before a more rigorous EU regulatory framework for risk assessment came into force. However, there are doubts that the application was actually filed in time.

Genetic engineering and species protection during the corona crisis: More precaution!

What does COVID-19 mean for genetic engineering?

9. April 2020 / Every crisis is an opportunity to learn for the future. So, what does COVID-19 mean for the ongoing debate around genetic engineering and the protection of biodiversity?

New report: strict regulation of new genomic techniques is scientifically necessary

Environmental impacts of CRISPR/Cas and its challenges for risk assessment

17 March 2020 / In a new report, Testbiotech provides an overview of the latest research developments in environmental risk assessment and new methods of genetic engineering (also known as ‘genome editing’ or ‘new genomic technicques’). The authors come to the conclusion there are imperative scientific reasons for all organisms derived from these new techniques to undergo mandatory risk assessment before they can be released or marketed. Therefore, regulation requirements foreseen by current GMO law in the EU must be mandatory whether or not additional DNA sequences are inserted.

Will there be GMO fast track approvals in the EU?

Testbiotech warns about planned trade deal with the US

9 March 2020 / Testbiotech warned in a letter to the EU Commission against a planned trade agreement between the EU and the Trump administration. The deal might allow fast track approvals for genetically engineered plants. Such plans were reported by the media in Brussels. They would be contrary to the views of many experts in EU member states and independent scientists, who have repeatedly drawn attention to substantial insufficiencies and gaps in current EU risk assessment.

Pages

Alle | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009